Letter to the Editor Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/Neuroscience.1.002
Association of COVID-19 coronavirus and Kawasaki syndrome like features in 1-5 years old children
Bittmann S1,*, Weissenstein A1, Villalon G1, Elena Moschüring-Alieva1, Luchter E1
- 1Department of Pediatrics, Ped Mind Institute (PMI), Gronau, Germany
Corresponding Author
Stefan Bittmann, stefanbittmann@gmx.de
Received Date: May 02, 2020
Accepted Date: May 04, 2020
Bittmann S, Weissenstein A, Villalon G, Moschüring-Alieva E, Luchter E. Association of COVID-19 coronavirus and Kawasaki syndrome like features in 1-5 years old children.Neurosci Chron 2020; 1(1):4-5.
Copyright: © 2020 Bittmann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Role of Ginseng in therapeutic management of Alzheimer’s Disease
While much of research progress has been achieved in last century on Alzheimer’s Disease (AD), the conclusive therapy for the same is still unachieved. Several lines of therapeutic regimes have been introduced, which basically act on slowing down the disease progression.
MicroRNA silencing: A promising therapy for Alzheimer’s disease
Alzheimer’s disease (AD) is a global health crisis currently afflicting ~6 million Americans (and ~40 million people worldwide). By the middle of the century, these numbers will stagger by ~16 million Americans (and ~152 million people worldwide) suffering from AD, if breakthrough disease-modifying treatments are not discovered.
The role of psychoeducation and yoga in reducing the burden of family caregivers of people with Alzheimer’s disease
The continuous increase in the elderly population and chronic health conditions present significant challenges to healthcare systems, particularly in developing countries. Among these conditions, dementia, particularly Alzheimer's disease (AD), is one of the most concerning, causing cognitive decline, behavioral changes, and progressive dependence on family caregivers.
Complex actions of amyloid beta on hippocampal neurogenesis in Alzheimer’s disease pathogenesis
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and memory impairment. One of the key pathological hallmarks of AD is the accumulation of amyloid beta (Aβ), a peptide derived from the sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases .
Sex differences in neuroplasticity and Alzheimer’s disease: A comprehensive review
Alzheimer’s disease (AD) is the leading cause of dementia, defined by amyloid plaques and neurofibrillary tangles. Yet, variability in disease onset and progression cannot be explained solely by pathology. Neuroplasticity, the brain’s ability to reorganize and adapt, is increasingly recognized as central to resilience in AD, with compelling evidence that it differs between sexes.